These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29598957)

  • 21. Fatal adverse drug reactions in children: A descriptive study in the World Health Organization pharmacovigilance database, 2010-2019.
    Montastruc JL
    Br J Clin Pharmacol; 2023 Jan; 89(1):201-208. PubMed ID: 35881623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
    Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
    Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serious adverse drug reactions in older adults notified to pharmacovigilance.
    Charfi R; El Aïdli S; Zaïem A; Kastalli S; Sraïri S; Daghfous R; Lakhal M
    Therapie; 2012; 67(5):465-70. PubMed ID: 23241256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase.
    Motola D; Donati M; Biagi C; Calamelli E; Cipriani F; Melis M; Monaco L; Vaccheri A; Ricci G
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1164-1171. PubMed ID: 28653802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recording and assessment of medication errors : Experience of the Drug Commission of the German Medical Association].
    Köberle U; Stammschulte T; Gundert-Remy U; Pitzer M; Bräutigam K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Sep; 61(9):1066-1074. PubMed ID: 30022236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study.
    Viola E; Trifirò G; Ingrasciotta Y; Sottosanti L; Tari M; Giorgianni F; Moretti U; Leone R
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):61-67. PubMed ID: 27875919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily.
    Nasso C; Mecchio A; Rottura M; Valenzise M; Menniti-Ippolito F; Cutroneo PM; Squadrito V; Squadrito F; Pallio G; Irrera N; Arcoraci V; Altavilla D
    Front Pharmacol; 2020; 11():1090. PubMed ID: 32765282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy.
    Carnovale C; Brusadelli T; Zuccotti G; Beretta S; Sullo MG; Capuano A; Rossi F; Moschini M; Mugelli A; Vannacci A; Laterza M; Clementi E; Radice S;
    Expert Opin Drug Saf; 2014 Sep; 13 Suppl 1():S1-8. PubMed ID: 25171154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children - A c4c expert group white paper.
    Aurich B; Apele-Freimane D; Banaschewski T; Chouchana L; Day S; Kaguelidou F; Kelly LE; Kindblom JM; Neubert A; Wong ICK
    Br J Clin Pharmacol; 2022 Dec; 88(12):4997-5016. PubMed ID: 34699077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety profile of etifoxine: A French pharmacovigilance survey.
    Cottin J; Gouraud A; Jean-Pastor MJ; Dautriche AD; Boulay C; Geniaux H; Auffret M; Bernard N; Descotes J; Vial T
    Fundam Clin Pharmacol; 2016 Apr; 30(2):147-52. PubMed ID: 26588183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the Methods to Obtain Paediatric Drug Safety Information: Spontaneous Reporting and Healthcare Databases, Active Surveillance Programmes, Systematic Reviews and Meta-analyses.
    Gentili M; Pozzi M; Peeters G; Radice S; Carnovale C
    Curr Clin Pharmacol; 2018; 13(1):28-39. PubMed ID: 29412117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase.
    Cliff-Eribo KO; Choonara I; Dodoo A; Darko DM; Sammons H
    Expert Opin Drug Saf; 2015; 14(12):1827-33. PubMed ID: 26436964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study.
    Caldeira D; Rodrigues R; Abreu D; Anes AM; Rosa MM; Ferreira JJ
    Expert Opin Drug Saf; 2018 Apr; 17(4):339-345. PubMed ID: 29463153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessment of an active pharmacovigilance system carried out by a pharmacist].
    Sánchez I; Amador C; Plaza JC; Correa G; Amador R
    Rev Med Chil; 2014 Aug; 142(8):998-1005. PubMed ID: 25424672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacovigilance implemented by patients: A necessity in the 21st century.
    Lafond J
    Therapie; 2016 Apr; 71(2):245-7. PubMed ID: 27080846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug reactions to self-medication: a study in a pharmacovigilance database.
    Berreni A; Montastruc F; Bondon-Guitton E; Rousseau V; Abadie D; Durrieu G; Chebane L; Giroud JP; Bagheri H; Montastruc JL
    Fundam Clin Pharmacol; 2015 Oct; 29(5):517-20. PubMed ID: 26215671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
    Sommet A; Durrieu G; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.